Neuroscience, and especially research into Alzheimer’s disease, has yielded nothing but failure from biopharma over the past 15 years. CRO Charles River Laboratories has signed up to a consortium aimed at reversing this poor hit rate.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,